Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 25, 2025
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
GlobeNewswire
·
March 25, 2025
MENLO PARK, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to …
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 25, 2025
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President …
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
GlobeNewswire
·
March 25, 2025
— Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) infections — SILVER SPRING, Md., March 25, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or …
Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025
GlobeNewswire
·
March 25, 2025
TARRYTOWN, N.Y., March 25, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2025 financial and operating results on Tuesday, April 29, 2025, before the U.S. financial markets open …
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 25, 2025
ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate …
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
GlobeNewswire
·
March 25, 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative …
Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment
GlobeNewswire
·
March 25, 2025
Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of …
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
GlobeNewswire
·
March 25, 2025
IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2024 …
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 25, 2025
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and Novel Mechanism of Action Registration Phase 3 Clinical …
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
March 25, 2025
DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has commenced an …
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today …
A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024
EIN Presswire
·
March 25, 2025
The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /EINPresswire.com/ -- The A' Wellness, Health Promotion, and Preventive …
Animal Protection Groups Petition Minnesota Court to Issue Search Warrant to Investigate Jennie-O Over Use of VSD+
GlobeNewswire
·
March 25, 2025
LITCHFIELD, Minn., March 25, 2025 (GLOBE NEWSWIRE) -- This week, the Animal Legal Defense Fund (ALDF) and Animal Partisan filed an application to the Eighth Judicial District Court in Meeker County, Minnesota, to obtain a court-issued search warrant and …
Prime Biome Reviews (MEDICAL ANALYSIS) What Real Users Say About Its Gut & And Gut Resetting Formula
GlobeNewswire
·
March 25, 2025
HAMPTON, March 25, 2025 (GLOBE NEWSWIRE) -- Prime Biome Gut health and skin care have always been treated as separate issues, with people relying on skincare products for clearer skin and digestive aids for bloating or discomfort. But what if the secret to …
UPDATE -- Recovery First Treatment Center’s New Executive Director Pledges to Expand Access, Strengthen Addiction Treatment Services
GlobeNewswire
·
March 25, 2025
HOLLYWOOD, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- As the overdose crisis continues to affect communities across South Florida, Recovery First Treatment Center has appointed Mercy Estevez, MSW, LCSW, as its new executive director. With over 15 years of …
Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders
EIN Presswire
·
March 25, 2025
BRADENTON, FL, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …
Ransomed Bodies Unveils Revolutionary Fitness Programs Designed for Every Body Type and Fitness Level
GlobeNewswire
·
March 25, 2025
Mission Viejo, Ca, March 25, 2025 (GLOBE NEWSWIRE) -- Ransomed Bodies, founded by fitness expert and former orthopedic surgery PA, Trent Harrison, is transforming the way individuals approach health and fitness with its innovative training programs. …
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
GlobeNewswire
·
March 25, 2025
WARREN, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug discovery, today announced the …
Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA
EIN Presswire
·
March 25, 2025
Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Acclaim Autism is thrilled to announce …
Mitolyn Reviews & Complaints (MEDICAL ANALYSIS): Is Mitochondrial Enhancement the Secret to Losing Weight In 2025?
GlobeNewswire
·
March 25, 2025
Mitolyn HAMPTON, Virginia, March 25, 2025 (GLOBE NEWSWIRE) -- When it comes to weight loss supplements, consumer experiences and real-world results matter more than marketing hype. With Mitolyn gaining rapid attention, people are asking the same questions …